SHARPE
Reported results
- Net income (GAAP): $220 million for Q3 2026, up 6% from $208 million in Q2 2026
- Operating net income (non-GAAP): $229 million for Q3 2026, up 6% from $217 million in Q2 2026
- Earnings per common share - diluted (GAAP): $0.78 for Q3 2026, up from $0.73 in Q2 2026
- Operating earnings per common share - diluted (non-GAAP): $0.82 for Q3 2026, up from $0.76 in Q2 2026
- Net interest margin: 4.11% in Q3 2026, up 18 basis points from 3.93% in Q2 2026
- Return on average assets (GAAP): 1.34% for Q3 2026, up from 1.27% in Q2 2026
Guidance
- Board authorized new $1.2 billion share repurchase program with no expiration date
- Declared quarterly cash dividend of $0.37 per common share on August 14, 2026, paid September 14, 2026
Notes
Company completed previous share repurchase authorization in Q3 2026, repurchasing 23.3 million common shares at average price of $29.88 from November 2025 through September 30, 2026. In September 2026, subsidiary issued $250 million subordinated notes due 2036 at 6.721% fixed rate for first five years. Company intends to redeem approximately $240 million of junior subordinated debentures in Q4 2026 and early 2027. Estimated regulatory capital ratios pending completion of filing.
Price and volatility reaction
The stock moved +3.2% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved +0.2 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 29.89 | 2026-10-22 |
| Close after release | 30.86 | 2026-10-23 |
| Realised move | +3.2% | close to close |
| 30d ATM IV change | +0.2 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-22 (8-K, Item 2.02). Read the original filing on sec.gov.